73% of pharma units in Maharashtra complied revised Schedule M norms (PharmaBiz)
Almost 73 per cent of the pharmaceutical units in Maharashtra have complied with revised Schedule M norms, even as 25 per cent of the units lost their licenses for non compliance with the standards till May 2008, according to the records with the Maharashtra state Food and Drugs Administration (FDA).

Learn about the World Ophthalmic Pharmaceutical Drugs Market (Marketwire via Yahoo! Finance)
Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.

ARX's CoSign Digital Signature Solution Provides Security, FDA Compliance and Annual Cost Savings of $150,000 for MEDRAD (PR Newswire via Yahoo! Finance)
DIA Conference -- A recent analysis by MEDRAD, a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body, found that the ARX's CoSign digital signature technology will produce a cost savings of $150,000 annually.